Answers are grounded in this paper and cite their sources.
Observational analysis shows smoking may correlate with higher mortality rates in melanoma, suggesting a need for routine status assessment.
Melanoma has emerged as a significant global health issue in recent decades, especially in countries with a predominantly fair-skinned population. Well recognized risk factors for melanoma include exposure to ultraviolet radiation, fair skin phototypes and a familial predisposition to malignant skin conditions. Although smoking is a well-known carcinogen, its impact on melanoma has been under-researched and is not routinely assessed during melanoma patient examinations. Existing studies suggest a correlation between smoking and adverse prognostic factors in melanoma, such as increased tumor thickness, ulceration and lymph node metastasis, leading to higher mortality rates independent of age, sex and disease stage. Surprisingly, some studies report a negative correlation between smoking and melanoma incidence, particularly in men, highlighting the need for further investigation. In light of the detrimental effects of smoking on melanoma prognosis, it is recommended to routinely assess smoking status — including former smoking habits — during initial evaluation and follow-up, and offer the patient support in quitting. Recognizing smoking as one of the key modifiable risk factors for cutaneous melanoma could be useful in reducing the disease’s impact and improving its outcome in these patients.
No takes yet. Share an insight, caveat, or question.
Negovetić et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: